Reference is made to the Company’s announcement dated 17 March 2023, the Company wishes to clarify on the reply to question no. 2 as follows:-
2) BCM’s direct and indirect shareholdings and warrant holdings in BSL before and after the Subscription.
Prior to the Subscription, BCM and BC Medicare’s direct and indirect shareholdings and warrants holdings in BSL should be as follows:-
BC Medicare
No. of Ordinary Shares
|
No. of Warrants B
|
Direct (%)
|
Indirect (%)
|
Direct (%)
|
Indirect (%)
|
6,500,000
(2.36%)
|
-
|
-
|
-
|
BCM
No. of Ordinary Shares
|
No. of Warrants B
|
Direct (%)
|
Indirect (%)
|
Direct (%)
|
Indirect (%)
|
-
|
6,500,000*
(2.36%)
|
-
|
-
|
Note:
*Deemed interested by virtue of the shares held in BC Medicare pursuant to Section 8 of the Companies Act 2016.
After the Subscription, BCM and BC Medicare’s direct and indirect shareholdings and warrant holdings in BSL are as follows:-
BC Medicare
No. of Ordinary Shares
|
No. of Warrants B
|
Direct (%)
|
Indirect (%)
|
Direct (%)
|
Indirect (%)
|
188,318,181
(9.76%)
|
-
|
75,757,575
(10.99%)
|
-
|
BCM
No. of Ordinary Shares
|
No. of Warrants B
|
Direct (%)
|
Indirect (%)
|
Direct (%)
|
Indirect (%)
|
-
|
188,318,181*
(9.76%)
|
-
|
75,757,575*
(10.99%)
|
Note:
*Deemed interested by virtue of the shares held in BC Medicare pursuant to Section 8 of the Companies Act 2016.
This announcement is dated 20 March 2023.